NEWS12 January 2010
US— Healthcare data and research firm SK&A has been sold to Cegedim Dendrite, a CRM services business focused on the life sciences industry.
SK&A holds contact and profiling information on more than two million healthcare practitioners, which Cegedim plans to use to bolster its OneKey database services in the US.
Dave Escalante, SK&A’s president and CEO, will continue to lead the business in his new role of vice president of data and information solutions.
Cegedim Dendrite is part of the Cegedim Group, which has headquarters in France. Previous acquisitions include patient data firm Hospital Marketing Services and pharma intelligence firm Nomi.
The world's leading job site for research and insight
Resources Group
Insights Editor (Research Manager) – Leading Information Group (Professional Services)
c. £38,000 (negotiable)
Resources Group
Research Manager – Education Research – Leading Social Research Agency
£35,000–£47,000 + strong benefits
Resources Group
Senior Research/Insight Executive (Client Side) – Not-For-Profit/Sustainability
£39–41,000
-
Brought to you by:
©2024 The Market Research Society,
15 Northburgh Street, London EC1V 0JR
Tel: +44 (0)20 7490 4911
info@mrs.org.uk -
© Copyright 2024 Research Live
1 Comment
Ishwar
15 years ago
I believe that Cegedim could be a major contender as a data vendor, but I feel that general information like prescriber information should be readily available to pharma companies via a congregated effort by them which would bring doen their data acquisition costs significantly.
Like Reply Report